These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 22521638)

  • 1. Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
    Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X
    Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: Stroma and its current and emerging targeted therapies.
    Kota J; Hancock J; Kwon J; Korc M
    Cancer Lett; 2017 Apr; 391():38-49. PubMed ID: 28093284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix.
    Jiang H; Torphy RJ; Steiger K; Hongo H; Ritchie AJ; Kriegsmann M; Horst D; Umetsu SE; Joseph NM; McGregor K; Pishvaian MJ; Blais EM; Lu B; Li M; Hollingsworth M; Stashko C; Volmar K; Yeh JJ; Weaver VM; Wang ZJ; Tempero MA; Weichert W; Collisson EA
    J Clin Invest; 2020 Sep; 130(9):4704-4709. PubMed ID: 32749238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal biology and therapy in pancreatic cancer: a changing paradigm.
    Neesse A; Algül H; Tuveson DA; Gress TM
    Gut; 2015 Sep; 64(9):1476-84. PubMed ID: 25994217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of an in vitro 3D PDAC stroma rich spheroid model.
    Ware MJ; Keshishian V; Law JJ; Ho JC; Favela CA; Rees P; Smith B; Mohammad S; Hwang RF; Rajapakshe K; Coarfa C; Huang S; Edwards DP; Corr SJ; Godin B; Curley SA
    Biomaterials; 2016 Nov; 108():129-42. PubMed ID: 27627810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells.
    Apte MV; Wilson JS
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():69-74. PubMed ID: 22320920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pancreas cancer microenvironment.
    Feig C; Gopinathan A; Neesse A; Chan DS; Cook N; Tuveson DA
    Clin Cancer Res; 2012 Aug; 18(16):4266-76. PubMed ID: 22896693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins.
    Liot S; Balas J; Aubert A; Prigent L; Mercier-Gouy P; Verrier B; Bertolino P; Hennino A; Valcourt U; Lambert E
    Front Immunol; 2021; 12():612271. PubMed ID: 33889150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal biology and therapy in pancreatic cancer.
    Neesse A; Michl P; Frese KK; Feig C; Cook N; Jacobetz MA; Lolkema MP; Buchholz M; Olive KP; Gress TM; Tuveson DA
    Gut; 2011 Jun; 60(6):861-8. PubMed ID: 20966025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between Tumor and Stromal Cells in Pancreatic Ductal Adenocarcinoma.
    Sperb N; Tsesmelis M; Wirth T
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A bioengineered heterotypic stroma-cancer microenvironment model to study pancreatic ductal adenocarcinoma.
    Drifka CR; Eliceiri KW; Weber SM; Kao WJ
    Lab Chip; 2013 Oct; 13(19):3965-75. PubMed ID: 23959166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
    Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-stroma interactions in pancreatic ductal adenocarcinoma.
    Mahadevan D; Von Hoff DD
    Mol Cancer Ther; 2007 Apr; 6(4):1186-97. PubMed ID: 17406031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Landscape of Pancreatic Cancer Therapeutic Resistance Mechanisms.
    Chand S; O'Hayer K; Blanco FF; Winter JM; Brody JR
    Int J Biol Sci; 2016; 12(3):273-82. PubMed ID: 26929734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma.
    Elahi-Gedwillo KY; Carlson M; Zettervall J; Provenzano PP
    Cancer Res; 2019 Jan; 79(2):372-386. PubMed ID: 30401713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.
    Thomas D; Radhakrishnan P
    Mol Cancer; 2019 Jan; 18(1):14. PubMed ID: 30665410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.
    Bijlsma MF; van Laarhoven HW
    Cancer Metastasis Rev; 2015 Mar; 34(1):97-114. PubMed ID: 25566685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.
    Rucki AA; Zheng L
    World J Gastroenterol; 2014 Mar; 20(9):2237-46. PubMed ID: 24605023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional significance of macrophages in pancreatic cancer biology.
    Hu H; Jiao F; Han T; Wang LW
    Tumour Biol; 2015 Dec; 36(12):9119-26. PubMed ID: 26411672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer stroma: controversies and current insights.
    Ansari D; Carvajo M; Bauden M; Andersson R
    Scand J Gastroenterol; 2017; 52(6-7):641-646. PubMed ID: 28276831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.